A retrospective study of loss of response and primary non response to biologics in inflammatory bowel disease – ulcerative colitis and Crohn's Disease patients
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 10 Jul 2020 New trial record